Concepedia

C. Saunders

CS

Statistics

Publications

1

Citations

33

H-Index

1

Active since

2022

Affiliations

Mission Therapeutics (United Kingdom)(Current)

C. Saunders is an author at Mission Therapeutics (United Kingdom) specializing in epigenetics, immune checkpoint blockade combinations, and checkpoint modulation in cancer.

Publications per year

2022–2022

1

Publications

1

STC-15, an oral small molecule inhibitor of the RNA methyltransferase METTL3, inhibits tumour growth through activation of anti-cancer immune responses associated with increased interferon signalling, and synergises with T cell checkpoint blockade

Yaara Ofir-Rosenfeld, L. Vasiliauskaitė, C. Saunders et al. · European Journal of Cancer · 2022 · 33 citations · Full text

, , +17

1–1 of 1